Oncophage® patient-specific cancer vaccine
An investigational product
Complete Clinical Experience
| Disease area |
Phase |
Protocol |
Description |
Data |
Trial Status |
Renal cell carcinoma
(kidney cancer) |
1/2 |
C-100-03 |
Metastatic |
ASCO 1999
ASCO 2000 |
Complete |
| 2 |
C-100-07 |
Metastatic |
ASCO 2003 |
Closed to enrollment |
| 3 |
C-100-12 |
Nonmetastatic |
ASCO 2004 |
Closed to enrollment |
| Melanoma |
1/2 |
C-100-02 |
Metastatic |
AACR 2000 |
Complete |
| 2 |
C-100-06 |
Metastatic |
ASCO 2001
AACR/NCI/EORTC 2001
AACR 2002
ASCO 2002 |
Complete |
| 2 |
C-100-22 |
Metastatic
(combination treatment) |
ASCO 2004 |
Complete |
| 3 |
C-100-21 |
Metastatic |
ASCO 2006 |
Closed to enrollment |
| Lung cancer |
1/2 |
C-100-26 |
Nonmetastatic,
non-small cell |
Not available |
Closed to enrollment |
| Colorectal cancer |
2 |
C-100-05 |
Metastatic |
ASCO 2001
AACR 2002
ASCO 2002 |
Complete |
| Non-Hodgkin’s lymphoma |
2 |
C-100-09 |
Low-grade,
indolent |
ASCO 2003 |
Complete |
| Glioma |
1 |
investigator-
sponsored |
Recurrent |
Not available |
Open for enrollment |
| Pancreatic cancer |
1 |
C-100-01 |
Metastatic |
ASCO 1999
ECCO 2003 |
Complete |
| Gastric cancer |
1 |
C-100-04 |
Metastatic |
ASCO 2000
ASCO 2002 |
Complete |
|
